Clinical Trials Browser

Phase EARLY_PHASE1 × Prostatic Neoplasms × Flutamide × Clear all

NCT03507608 2025-10-16

Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression

Phase EARLY_PHASE1 Completed

25 enrolled 4 charts

Prostatic Neoplasms